As of 30 May 2014 the following were the holders of 3% or more of the company's issued ordinary share capital.
|Number of shares||Percentage|
|European Bioscience Fund I Limited||3,305,221||19%|
|Goodbody Stockbroker Nominees||3,041,663||18%|
|Growcorp Group Limited||2,608,698||15%|
|Pershing International Nominee||996,176||6%|
|Michael J. McKenna||694,198||4%|
|Kernal Capital Partners||571,163||3%|
There are 18,615,777 ordinary shares of €0.01 outstanding and there are no restrictions on shares.